To include your compound in the COVID-19 Resource Center, submit it here.

HylatopicPlus Emollient Foam: Postmarketing study data

An open-label postmarketing study in 30 patients showed that HylatopicPlus Emollient Foam produced 67.9% improvement

Read the full 158 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE